SRD signs agreement with OmniComm to build and support two studies with TrialMaster®Wednesday, August 9, 2017
TrialMaster was selected for its speed of study build, flexibility and multilingual capabilities, but most of all, for its unique ability to both transpose data and export data in SDTM format directly from the EDC solution. Compelling TrialMaster features include: intuitive user interface, real-time edit checks, real-time reporting and the ability to customize data exports. OmniComm’s technology transition deployment model, which allows customers to build their studies while OmniComm manages the hosting in its state-of-the-art data centers, was another critical factor in the selection process.
“We started preparing to bring TrialMaster to the Japanese market in 2016. In Japan, more so than any other country, it requires not only a superior product, but above all, endurance and focus to bring a new technology to the market and secure your first customers,” said Wolf Ondracek, senior vice president at OmniComm, with responsibility for the Asia-Pacific region. “The fact that SRD, a local Japanese CRO, has chosen TrialMaster as its EDC system for industry-sponsored trials is a tremendously important milestone. I am confident that it marks the start of the successful penetration of the Japanese market for our flagship EDC solution, TrialMaster.”
Specific emphasis for TrialMaster’s selection included:
- Ability to build studies more efficiently and effectively.
- Adeptness in query management work flow.
- Intuitive interface for all key user groups.
- Dynamic monitoring and centralized source review.
- Ability to export SDTM datasets directly from TrialMaster using Custom Export Utility Tool™.
- Broad range of pre-built, real-time standard reports and best-in-class, real-time ad-hoc reporting.
- Flexible and very user-friendly eLearning modules.
- Professional and experienced regional-based services and support organization.
About OmniComm Systems, Inc.
OmniComm Systems, Inc. is a leading strategic software solutions provider to the life sciences industry. OmniComm is dedicated to helping the world’s pharmaceutical, biotechnology, contract research organizations, diagnostic and device firms, and academic medical centers maximize the value of their clinical research investments. Through the use of innovative and progressive technologies, these organizations drive efficiency in clinical development, better manage risks, ensure regulatory compliance and manage their clinical operations performance. OmniComm provides comprehensive solutions for clinical research with an extensive global experience from more than 5,000 clinical trials. For more information, please visit: omnicomm.com
About SRD Co., Ltd.
SRD is a Tokyo-based, mid-size Japanese CRO, established in 1989. The company offers a full range of CRO services, including monitoring, QA and GCP services, data management and biostatistics, drug management, medical writing, pharmacovigilance and regulatory consulting. For further details, please visit: http://www.cro-srd.co.jp/
OmniComm, TrialMaster, TrialOne, and Promasys are registered trademarks of OmniComm Systems, Inc. Other names may be trademarks of their respective owners.
HALIX started construction activities for the new facility
Gilead and Galapagos announce results with filgotinib in the phase 2 equator study in psoriatic arthritis and progression into phase 3 for the selection study in ulcerative colitis
ProQR Initiates Phase 1/2 Clinical Trial of QR-313 for Dystrophic Epidermolysis Bullosa